In the APPPS1 and R1.40 mouse models of amyloidosis, Cx3cr1 deficiency results in a gene-dose dependent reduction in fibrillar Aβ (fAβ) burdens in early disease, suggesting that a loss of CX3CR1 is beneficial in Aβ pathogenesis. Here, CX3CR1 is linked to amyloidosis.